Patient info

Lamisil at 1% cream – patient leaflet, side effects, dosage

Updated:
Key facts
Status:
General sale (GSL)
Medicine strength:
1% (10 mg/gram)
Other strengths and forms:
Contains active substance:

Patient leaflet - Lamisil at 1% cream

1. WHAT LAMISIL AT 1% CREAM IS AND WHAT IT IS USED FOR

Lamisil AT 1% Cream contains the active ingredient terbinafine hydrochloride which is an antifungal used to treat fungal skin infections such as:

  • Athlete’s foot (tinea pedis) – Athlete’s foot appears only on the feet (usually both, but not always), usually in between the toes. It can also appear on the instep, soles, or other areas of the feet. The most common type of athlete’s foot causes cracking or scaling of the skin, but you may also have mild swelling, blisters, or weeping ulcers. Lamisil AT 1% Cream is recommended for athlete’s foot when it occurs between the toes. If you have a fungal nail infection (fungus inside and under the nail) with discolouration of the nails and changes in nail texture (thick or flaky), you should consult your doctor because Lamisil AT 1% Cream is not appropriate for this type of infection.
  • Dhobie itch/jock itch (tinea cruris) – Dhobie itch appears in the groin and inner thigh area, usually on both sides but often with one side more than the other, where it can spread further between the legs to the buttocks, or up towards the stomach. Dhobie itch looks like a clearly bordered rash, which may have blisters.

2. BEFORE YOU USE LAMISIL AT 1% CREAM

DO NOT use Lamisil AT 1% Cream if you:

  • are allergic (hypersensitive) to any of the ingredients in the product (see Section 6).

The cream is NOT recommended for use on children under 16 years of age.

Take special care with Lamisil AT 1% cream

The cream is for external use only. Do not use on the face. Avoid contact with the eyes. In case of accidental contact with eyes, rinse thoroughly with running water.

Taking other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including those obtained without a prescription.

Pregnancy and breast-feeding

Do not use the cream if you are pregnant or breastfeeding, unless advised to by your doctor.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Lamisil AT 1% Cream is not expected to affect your ability to drive or operate machinery.

Important information about some of the ingredients of Lamisil AT 1% Cream

  • Lamisil AT 1% Cream contains 36 mg benzyl alcohol in each daily dosage which is equivalent to 10 mg/g. Benzyl alcohol may cause allergic reactions.
  • Cetyl alcohol and stearyl alcohol: may cause local skin reactions (e.g. contact dermatitis).

3. HOW TO USE LAMISIL AT 1% CREAM

Always use this medicine exactly as described in this leaflet or as advised by your doctor or pharmacist.

Adults

For athlete's foot and dhobie itch, apply the cream once a day, for one week.

  • Cleanse and dry the affected areas thoroughly and wash your hands. Treatment can be helped by keeping the affected areas clean by regular washing and careful drying with your own clean towels and clothes, and not rubbing or scratching the skin.
  • Unscrew the cap then gently squeeze out a small amount of the cream onto your finger.
  • Apply just enough cream to form a thin layer on the affected skin and surrounding areas.
  • Rub in gently. When used between the toes, buttocks or on the groin, the treated area may be covered with a light, fresh gauze strip, especially at night.
  • Replace the cap on the tube and wash your hands. Even though you will not be using Lamisil AT 1% Cream during the second week, full skin healing after the

    2003473_1/62000000208851 1% CREAM

Terbinafine Hydrochloride

infection has cleared will continue for up to 4 weeks. If you have not noticed any signs of improvement within 2 weeks of first starting treatment, please seek advice from your doctor or pharmacist.

Children under 16 years

NOT recommended.

If you accidently swallow Lamisil AT 1% Cream

Contact your doctor or nearest hospital emergency department if you, or someone else, has swallowed some cream. Take any remaining medicine and this leaflet with you if possible. Symptoms of accidental ingestion include headache, nausea (feeling sick), dizziness and stomach pain.

If you forget to use Lamisil AT 1% Cream

If you miss an application, apply the cream as soon as possible then continue your treatment as before. If you only remember at the time of your next application, just apply the cream and carry on as normal. It is important to try to use the cream at the correct times as forgotten applications could risk the infection returning.

If you stop using Lamisil AT 1% Cream

Infections may come back if you do not use the cream regularly, or if you stop the treatment too early. If you have any further questions on the use of this product, ask your doctor or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, Lamisil AT 1% Cream can cause side effects, although not everybody gets them.

STOP using the cream and seek medical help immediately if you have any of the following very rare allergic reactions:

  • difficulty breathing or swallowing, swelling of the mouth, face, lips, tongue or throat (severe allergic reaction)
  • severe itching of the skin, with a red rash or raised lumps, hives or blisters.

Common (may affect up to 1 in 10 people): skin peeling, itching.

Uncommon (may affect up to 1 in 100 people): skin lesions, scab, skin colour changes, redness, burning, pain and irritation at the site of application.

These common and uncommon side effects are usually harmless and you can carry on using the cream. Rare (may affect up to 1 in 1000 people): eye irritation, dry skin, contact dermatitis, eczema, worsening of symptoms. Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE LAMISIL AT 1% CREAM

Keep out of the sight and reach of children.

Keep the tube closed and in the carton.

Do not use this medicine after the expiry (EXP) date shown on the box and tube.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. FURTHER INFORMATION

What Lamisil AT 1% Cream contains

The active ingredient is terbinafine hydrochloride 1% w/w.

The other ingredients are sodium hydroxide, benzyl alcohol, sorbitan stearate, cetyl palmitate, cetyl alcohol, stearyl alcohol, polysorbate 60, isopropyl myristate, purified water. (See also end of Section 2 for further information on some of the ingredients).

What Lamisil AT 1% Cream looks like and contents of the pack

The cream is available in aluminium or laminate tubes of 7 g, 7.5 g, 10 g or 15 g.

Not all pack sizes may be marketed.

Marketing Authorisation Holder:

Karo Healthcare AB, Box 16184,

103 24 Stockholm, Sweden.

Manufacturer:

GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.

This leaflet was last revised in December 2023.

2003473_1/62000000208851

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 50567/0018

Last revision stated in the text: December 2023 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Lamisil at 1% cream

Prescription needed? No, general sale list medicine (GSL) – also sold outside pharmacies
Active substance Terbinafine
Strength 1% (10 mg/gram)
Pharmaceutical form Cutaneous cream
How is it taken Cutaneous
Excipients Sodium hydroxide, benzyl alcohol, sorbitan stearate, cetyl palmitate, cetyl alcohol, stearyl alcohol, polysorbate 60, isopropyl myristate, purified water.
Pack sizes 7.5 gram, 15 gram
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Aluminium tube: 3 years
Polypropylene dispenser: 3 years
Storage None.
Drug group (ATC)
  1. D Dermatologicals
    1. D01 Antifungals for dermatological use
      1. D01A Antifungals for topical use
        1. D01AE Other antifungals for topical use
          1. D01AE15 terbinafine
Marketing authorisation PL 50567/0018 (first authorised 10 February 2009)
Marketing authorisation holder Karo Healthcare AB
Codes GTIN 7311620012988, 7311620012995 · BNF 13100200

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.